MedPath

Survey Preference therapy the urologist who are affected even by a prostate cancer (PCA)

Conditions
C61
Malignant neoplasm of prostate
Registration Number
DRKS00009590
Lead Sponsor
niversitätsklinik für Urologie und Kinderurologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
11
Inclusion Criteria

Patients =40 years
- Disease-specific Men
- Urologists with PCA

Exclusion Criteria

Non

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The questionnaire is to examine the treatment preference of urology colleagues, which are themselves affected by prostate cancer. The two-page questionnaire with three-sided attachment is sent to all living urologist in Germany via e-mail distribution of the German Society of Urology (DGU). The data collection and analysis and the publication will be descriptive and anonymized.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath